Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic hepatitis C serine protease inhibitors

Macrocyclic hepatitis C serine protease inhibitors

US Patent 8937041 · Granted Jan 20, 2015

Estimated economic value: $146,470,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Display substrate, manufacturing method thereof and display apparatus2025
Anti-alpha-4-beta-7 antibodies2023
Method and apparatus for lifting heavy load2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2020
Bromodomain inhibitors2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2019
Substituted pyrrolidines and methods of use2019
Bromodomain inhibitors2018